Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
NewGenIVF exchanged existing convertible notes for a new senior convertible note with amended terms, closing the transaction on August 14, 2026.
The restructuring eliminates the mandatory requirement that proceeds from new capital raises be used to prepay the notes, providing greater flexibility and removing a restrictive covenant.
CEO Alfred Siu stated the exchange improves the capital structure and better supports the company's strategic objectives and long-term growth.